Hayden Eastbury spreads awareness of fragile X syndrome across ABC’s newsrooms
For Newcastle local Hayden Eastbury, the ABC is not just something he tunes into each morning, noon, and…
Astrocytes Identified as Key Target for Treating Fragile X Syndrome
Summary: For years, researchers focusing on Fragile X syndrome (FXS), the most common cause of inherited intellectual disability,…
Nabsys Presents Novel Disease Insights and Advantages in Structural Variant Detection using OhmX™ Platform at American Society of Human Genetics (ASHG) 2025 Annual Meeting
Multi-omics study utilizing electronic genome mapping (EGM) reveals 70% of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) have…
Harmony Biosciences’ Genetic Disorder Drug Disappoints In Phase 3 Study
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) released topline results from its Phase 3 registrational clinical trial (the RECONNECT Study)…
Harmony Biosciences’ Genetic Disorder Drug Disappoints In Phase 3 Study
Harmony Biosciences’ Genetic Disorder Drug Disappoints In Phase 3 Study Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) released topline results…
PacBio Targets Carrier Screening, Aims to Simplify Genetic Testing
PacBio is known in the genomics space for its HiFi sequencing technology—which provides long, highly accurate reads. But…